Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at ZAR 390.8B, ahead of BioNTech (ZAR 367.2B) and Biogen (ZAR 314.3B). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesZAR 390.8B
Median
ZAR 34.7B
Combined market value
ZAR 14.62T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareZAR 390.8BZAR 3.64TZAR 2,930.92 1.60% up 33% up United States
2BioNTechBNTX · Health CareZAR 367.2BZAR 362.2BZAR 1,460.81 0.47% down 16% down Germany
3BiogenBIIB · Health CareZAR 314.3BZAR 638.2BZAR 4,317.20 0.34% down 49% up United States
4AmgenAMGN · Health CareZAR 149BZAR 4.26TZAR 7,882.99 0.95% down 34% up United States
5ModernaMRNA · Health CareZAR 148.9BZAR 1.44TZAR 3,559.94 3.93% down 755% up United States
6argenxARGX · Health CareZAR 126.1BZAR 1.03TZAR 16,310.99 0.36% down 4% up Belgium
7QiagenQGEN · Health CareZAR 65BZAR 176.8BZAR 856.42 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareZAR 56BZAR 289.1BZAR 2,856.21 0.37% up 20% up United States
9VaxcytePCVX · Health CareZAR 46.2BZAR 161.9BZAR 1,022.54 3.59% down 22% up United States
10ExelixisEXEL · Health CareZAR 37.2BZAR 287.7BZAR 1,179.19 2.09% up 63% up United States
11Bio-TechneTECH · Health CareZAR 36.3BZAR 196.4BZAR 1,250.28 0.22% down 26% up United States
12RepligenRGEN · Health CareZAR 36.3BZAR 178.5BZAR 2,791.83 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareZAR 33.1BZAR 67BZAR 691.16 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareZAR 28.1BZAR 605.8BZAR 2,800.61 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareZAR 27.2BZAR 178.6BZAR 2,091.89 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareZAR 21BZAR 152.3BZAR 5,139.36 0.22% up 46% up United States
17ImmunovantIMVT · Health CareZAR 14.7BZAR 118.3BZAR 571.69 0.21% down 43% up United States
18CG OncologyCGON · Health CareZAR 13BZAR 121.4BZAR 1,358.90 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareZAR 8.1BZAR 131.4BZAR 1,928.01 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareZAR 4.2BZAR 94.7BZAR 776.03 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareZAR 3.8BZAR 79.4BZAR 490.44 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareZAR 2.7BZAR 109BZAR 1,666.35 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareZAR 840.3MZAR 188.4BZAR 1,652.07 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-ZAR 8.6BZAR 114.6BZAR 107.76 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2144 ZAR).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (ZAR 390.8B), BioNTech (ZAR 367.2B) and Biogen (ZAR 314.3B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:23 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of ZAR 14.62T as of 18 Nov 2026, 14:23 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.